Does RIPRETINIB Cause Product dose omission in error? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Product dose omission in error have been filed in association with RIPRETINIB (QINLOCK). This represents 1.5% of all adverse event reports for RIPRETINIB.
67
Reports of Product dose omission in error with RIPRETINIB
1.5%
of all RIPRETINIB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Product dose omission in error From RIPRETINIB?
Of the 67 reports, 13 (19.4%) required hospitalization.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
Which RIPRETINIB Alternatives Have Lower Product dose omission in error Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID